AIM: To determine whether an intensive intervention at a heart failure (HF) clinic by a combination of a clinician and a cardiovascular nurse, both trained in HF, reduces the incidence of hospitalisation for worsening HF and/or all-cause mortality (primary end point) and improves functional status (including left ventricular ejection fraction, New York Heart Association (NYHA) class and quality of life) in patients with NYHA class III or IV. SETTING:Two regional teaching hospitals in The Netherlands. METHODS:240 patients were randomly allocated to the 1-year intervention (n = 118) or usual care (n = 122). The intervention consisted of 9 scheduled patient contacts-at day 3 by telephone, and at weeks 1, 3, 5, 7 and at months 3, 6, 9 and 12 by a visit-to a combined, intensive physician-and-nurse-directed HF outpatient clinic, starting within a week after hospital discharge from the hospital or referral from the outpatient clinic. Verbal and written comprehensive education, optimisation of treatment, easy access to the clinic, recommendations for exercise and rest, and advice for symptom monitoring and self-care were provided. Usual care included outpatient visits initialized by individual cardiologists in the cardiology departments involved and applying the guidelines of the European Society of Cardiology. RESULTS: During the 12-month study period, the number of admissions for worsening HF and/or all-cause deaths in the intervention group was lower than in the control group (23 vs 47; relative risk (RR) 0.49; 95% confidence interval (CI) 0.30 to 0.81; p = 0.001). There was an improvement in left ventricular ejection fraction (LVEF) in the intervention group (plus 2.6%) compared with the usual care group (minus 3.1%; p = 0.004). Patients in the intervention group were hospitalised for a total of 359 days compared with 644 days for those in the usual care group. Beneficial effects were also observed on NYHA classification, prescription of spironolactone, maximally reached dose of beta-blockers, quality of life, self-care behaviour and healthcare costs. CONCLUSION: A heart failure clinic involving an intensive intervention by both a clinician and a cardiovascular nurse substantially reduces hospitalisations for worsening HF and/or all-cause mortality and improves functional status, while decreasing healthcare costs, even in a country with a primary-care-based healthcare system.
RCT Entities:
AIM: To determine whether an intensive intervention at a heart failure (HF) clinic by a combination of a clinician and a cardiovascular nurse, both trained in HF, reduces the incidence of hospitalisation for worsening HF and/or all-cause mortality (primary end point) and improves functional status (including left ventricular ejection fraction, New York Heart Association (NYHA) class and quality of life) in patients with NYHA class III or IV. SETTING: Two regional teaching hospitals in The Netherlands. METHODS: 240 patients were randomly allocated to the 1-year intervention (n = 118) or usual care (n = 122). The intervention consisted of 9 scheduled patient contacts-at day 3 by telephone, and at weeks 1, 3, 5, 7 and at months 3, 6, 9 and 12 by a visit-to a combined, intensive physician-and-nurse-directed HF outpatient clinic, starting within a week after hospital discharge from the hospital or referral from the outpatient clinic. Verbal and written comprehensive education, optimisation of treatment, easy access to the clinic, recommendations for exercise and rest, and advice for symptom monitoring and self-care were provided. Usual care included outpatient visits initialized by individual cardiologists in the cardiology departments involved and applying the guidelines of the European Society of Cardiology. RESULTS: During the 12-month study period, the number of admissions for worsening HF and/or all-cause deaths in the intervention group was lower than in the control group (23 vs 47; relative risk (RR) 0.49; 95% confidence interval (CI) 0.30 to 0.81; p = 0.001). There was an improvement in left ventricular ejection fraction (LVEF) in the intervention group (plus 2.6%) compared with the usual care group (minus 3.1%; p = 0.004). Patients in the intervention group were hospitalised for a total of 359 days compared with 644 days for those in the usual care group. Beneficial effects were also observed on NYHA classification, prescription of spironolactone, maximally reached dose of beta-blockers, quality of life, self-care behaviour and healthcare costs. CONCLUSION: A heart failure clinic involving an intensive intervention by both a clinician and a cardiovascular nurse substantially reduces hospitalisations for worsening HF and/or all-cause mortality and improves functional status, while decreasing healthcare costs, even in a country with a primary-care-based healthcare system.
Authors: Edward K Kasper; Gary Gerstenblith; Gail Hefter; Elizabeth Van Anden; Jeffrey A Brinker; David R Thiemann; Michael Terrin; Sandra Forman; Sheldon H Gottlieb Journal: J Am Coll Cardiol Date: 2002-02-06 Impact factor: 24.094
Authors: Pieta W F Bruggink-André de la Porte; Dirk J A Lok; Jan van Wijngaarden; Jan H Cornel; Dian Pruijsers-Lamers; Dirk J van Veldhuisen; Arno W Hoes Journal: Eur J Heart Fail Date: 2005-08 Impact factor: 15.534
Authors: R N Doughty; S P Wright; A Pearl; H J Walsh; S Muncaster; G A Whalley; G Gamble; N Sharpe Journal: Eur Heart J Date: 2002-01 Impact factor: 29.983
Authors: L Blue; E Lang; J J McMurray; A P Davie; T A McDonagh; D R Murdoch; M C Petrie; E Connolly; J Norrie; C E Round; I Ford; C E Morrison Journal: BMJ Date: 2001-09-29
Authors: Kenneth McDonald; Mark Ledwidge; John Cahill; Peter Quigley; Brian Maurer; Bronagh Travers; Mary Ryder; Emma Kieran; Lorna Timmons; Enda Ryan Journal: J Card Fail Date: 2002-06 Impact factor: 5.712
Authors: Jonathan G Howlett; Robert S McKelvie; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Simon Kouz; Kori Leblanc; Peter Liu; Elizabeth Mann; Gordon W Moe; Eileen O'Meara; Miroslav Rajda; Samuel Siu; Paul Stolee; Elizabeth Swiggum; Shelley Zeiroth Journal: Can J Cardiol Date: 2010-04 Impact factor: 5.223
Authors: Nini H Jonkman; Heleen Westland; Rolf H H Groenwold; Susanna Ågren; Felipe Atienza; Lynda Blue; Pieta W F Bruggink-André de la Porte; Darren A DeWalt; Paul L Hebert; Michele Heisler; Tiny Jaarsma; Gertrudis I J M Kempen; Marcia E Leventhal; Dirk J A Lok; Jan Mårtensson; Javier Muñiz; Haruka Otsu; Frank Peters-Klimm; Michael W Rich; Barbara Riegel; Anna Strömberg; Ross T Tsuyuki; Dirk J van Veldhuisen; Jaap C A Trappenburg; Marieke J Schuurmans; Arno W Hoes Journal: Circulation Date: 2016-02-12 Impact factor: 29.690
Authors: Frank Peters-Klimm; Stephen Campbell; Katja Hermann; Cornelia U Kunz; Thomas Müller-Tasch; Joachim Szecsenyi Journal: Trials Date: 2010-05-17 Impact factor: 2.279
Authors: Dirk J A Lok; Peter Van Der Meer; Pieta W Bruggink-André de la Porte; Erik Lipsic; Jan Van Wijngaarden; Hans L Hillege; Dirk J van Veldhuisen Journal: Clin Res Cardiol Date: 2010-02-04 Impact factor: 5.460
Authors: Dirk J Lok; Sjoukje I Lok; Pieta W Bruggink-André de la Porte; Erik Badings; Eric Lipsic; Jan van Wijngaarden; Rudolf A de Boer; Dirk J van Veldhuisen; Peter van der Meer Journal: Clin Res Cardiol Date: 2012-08-12 Impact factor: 5.460
Authors: Frank Peters-Klimm; Stephen Campbell; Thomas Müller-Tasch; Dieter Schellberg; Goetz Gelbrich; Wolfgang Herzog; Joachim Szecsenyi Journal: Trials Date: 2009-08-13 Impact factor: 2.279